• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用代谢途径改善胰腺癌的诊断和治疗

Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.

机构信息

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI 48109, USA.

出版信息

Cancer Cell. 2017 Jan 9;31(1):5-19. doi: 10.1016/j.ccell.2016.12.006.

DOI:10.1016/j.ccell.2016.12.006
PMID:28073003
Abstract

Pancreatic ductal adenocarcinoma is on pace to become the second leading cause of cancer-related death. The high mortality rate results from a lack of methods for early detection and the inability to successfully treat patients once diagnosed. Pancreatic cancer cells have extensively reprogrammed metabolism, which is driven by oncogene-mediated cell-autonomous pathways, the unique physiology of the tumor microenvironment, and interactions with non-cancer cells. In this review, we discuss how recent efforts delineating rewired metabolic networks in pancreatic cancer have revealed new in-roads to develop detection and treatment strategies for this dreadful disease.

摘要

胰腺导管腺癌正成为第二大癌症相关死亡原因。高死亡率是由于缺乏早期检测方法,以及一旦确诊,无法成功治疗患者所致。胰腺癌广泛重编程代谢,这是由癌基因介导的细胞自主途径、肿瘤微环境的独特生理学以及与非癌细胞的相互作用驱动的。在这篇综述中,我们讨论了最近阐明胰腺癌中重布线代谢网络的努力如何为开发这种可怕疾病的检测和治疗策略开辟了新途径。

相似文献

1
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.利用代谢途径改善胰腺癌的诊断和治疗
Cancer Cell. 2017 Jan 9;31(1):5-19. doi: 10.1016/j.ccell.2016.12.006.
2
Targeting cancer cell metabolism in pancreatic adenocarcinoma.靶向胰腺腺癌中的癌细胞代谢。
Oncotarget. 2015 Jul 10;6(19):16832-47. doi: 10.18632/oncotarget.4160.
3
Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography imaging in pancreatic ductal adenocarcinoma patients with diabetes.糖尿病胰腺导管腺癌患者中,氟-18氟脱氧葡萄糖正电子发射断层扫描联合计算机断层扫描成像的最大标准化摄取值较低。
Am J Surg. 2015 Apr;209(4):709-16. doi: 10.1016/j.amjsurg.2014.06.038. Epub 2014 Dec 24.
4
Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.比较胰腺实性假乳头状瘤和胰腺导管腺癌的 F-18-FDG PET/CT 表现。
Eur J Radiol. 2014 Jan;83(1):231-5. doi: 10.1016/j.ejrad.2013.09.031. Epub 2013 Nov 14.
5
Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.胰腺癌基质的独特代谢特征:与肿瘤微环境、预后及侵袭潜能的相关性
Oncotarget. 2016 Nov 29;7(48):78396-78411. doi: 10.18632/oncotarget.11893.
6
Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma.肿瘤微环境的分子影像学揭示了胰腺导管腺癌中肿瘤氧合、葡萄糖摄取和糖酵解之间的关系。
Cancer Res. 2020 Jun 1;80(11):2087-2093. doi: 10.1158/0008-5472.CAN-19-0928. Epub 2020 Apr 3.
7
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.胰腺导管腺癌中宿主组织与免疫细胞的相互调控:新的见解和治疗意义。
Mol Cancer. 2019 Dec 13;18(1):184. doi: 10.1186/s12943-019-1117-9.
8
Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways.胰腺肿瘤细胞代谢:聚焦于糖酵解及其相关代谢途径。
Arch Biochem Biophys. 2014 Mar 1;545:69-73. doi: 10.1016/j.abb.2013.12.019. Epub 2014 Jan 3.
9
Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.通过靶向重编程代谢克服化疗耐药性:胰腺导管腺癌的阿喀琉斯之踵。
Cell Mol Life Sci. 2021 Jul;78(14):5505-5526. doi: 10.1007/s00018-021-03866-y. Epub 2021 Jun 15.
10
Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze.胰腺导管腺癌的代谢重编程:迷宫中可供追寻的新路径。
Int J Cancer. 2016 Feb 15;138(4):787-96. doi: 10.1002/ijc.29501. Epub 2015 Mar 18.

引用本文的文献

1
Semi-permeable polymer vesicle-based prooxidative and lactate-depleting nanoreactors with sustained activity against pancreatic cancer.基于半透性聚合物囊泡的具有持续抗胰腺癌活性的促氧化和乳酸消耗纳米反应器
Front Bioeng Biotechnol. 2025 Jun 26;13:1626927. doi: 10.3389/fbioe.2025.1626927. eCollection 2025.
2
Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma.与可切除胰腺导管腺癌相关的代谢物变化
Cancers (Basel). 2025 Mar 29;17(7):1150. doi: 10.3390/cancers17071150.
3
Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma.
蛋白质乳酰化水平升高促进胰腺导管腺癌的免疫抑制微环境和治疗抵抗。
J Clin Invest. 2025 Jan 30;135(7):e187024. doi: 10.1172/JCI187024.
4
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks.胰腺癌治疗中的一个绊脚石:耐药信号网络。
Front Cell Dev Biol. 2025 Jan 13;12:1462808. doi: 10.3389/fcell.2024.1462808. eCollection 2024.
5
The value of a metabolic and immune-related gene signature and adjuvant therapeutic response in pancreatic cancer.代谢和免疫相关基因特征在胰腺癌中的价值及辅助治疗反应
Front Genet. 2025 Jan 3;15:1475378. doi: 10.3389/fgene.2024.1475378. eCollection 2024.
6
Identification of Metabolic Characteristic-Pancreatic Ductal Adenocarcinoma Associations Using Mendelian Randomization and Metabolomics.利用孟德尔随机化和代谢组学鉴定代谢特征与胰腺导管腺癌的关联
J Gastrointest Cancer. 2025 Jan 20;56(1):48. doi: 10.1007/s12029-025-01173-4.
7
Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9.升高的固醇调节元件结合蛋白1通过靶向SOX9加速胰腺癌的起始和生长。
Biol Direct. 2025 Jan 14;20(1):6. doi: 10.1186/s13062-025-00595-1.
8
Metabolite Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: A Systematic Review.用于早期检测胰腺导管腺癌的代谢物生物标志物:一项系统综述。
Cureus. 2024 Nov 26;16(11):e74528. doi: 10.7759/cureus.74528. eCollection 2024 Nov.
9
Oncometabolites in pancreatic cancer: Strategies and its implications.胰腺癌中的肿瘤代谢物:策略及其影响
World J Exp Med. 2024 Dec 20;14(4):96005. doi: 10.5493/wjem.v14.i4.96005.
10
Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives.胰腺癌中的可塑性与肿瘤微环境:遗传学、代谢及免疫视角
Cancers (Basel). 2024 Dec 6;16(23):4094. doi: 10.3390/cancers16234094.